LINC01915 has been reported to inhibit the formation of CAFs through miR-92a-3p/KLF4/CH25H axis, which was consistent with our analysis that LINC01915 was downregulated in CRC compared with normal tissues [50]. Here, KLF4 is linked to colorectal carcinoma.